MOBILion Systems has achieved a decisive technical milestone through proof-of-concept demonstration that high-resolution ion mobility (HRIM), operated in MOBILion’s proprietary PAMAF mode, reshapes mass spectrometry-based proteomics. The findings underscore hardware limitations inherent to existing mass spectrometry architectures that cannot be addressed through software or existing hardware optimization, demonstrating a distinctive approach that current platforms cannot achieve without fundamental architectural change.
More than 25 years ago, leading experts identified a fundamental limitation in LC-MS/MS proteomics workflows, namely inherent ion utilization inefficiency that intensifies as analytical complexity increases. Despite advances in instrumentation and software, the field has remained constrained to incremental gains within the same LC-MS paradigm. MOBILion’s introduction of PAMAF as a new mode of operation delivered the technological breakthrough required to move beyond this long-standing constraint. Peer-reviewed evidence from MOBILion scientists and external collaborators now confirms that this approach has progressed from concept to reality.
Results include four peer-reviewed publications published, submitted and in preparation, six independent collaborator studies, and two invited presentations at major scientific conferences, demonstrating that MOBILion’s technology overcomes the tradeoff between sensitivity, specificity, and speed that has historically constrained conventional proteomics workflows. This new combination will drive more actionable outcomes in drug development, stronger biomarker and diagnostic discoveries, and deeper biological understanding.
MOBILion’s strategy is to integrate its HRIM technology across the mass spectrometry ecosystem, extending beyond proteomics into metabolomics, lipidomics, exposomics, and other high-value analytical markets.